Where does Novadaq Technologies ULC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Novadaq Technologies ULC ranks #10,710 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Novadaq Technologies ULC hold?

Novadaq Technologies ULC holds 29 US utility patents granted between 2018 and 2021, spanning 12 technology areas.

What is Novadaq Technologies ULC's Innovation Score?

Novadaq Technologies ULC has an Innovation Score of 37.9 out of 100 (top 42% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Novadaq Technologies ULC focus on?

Novadaq Technologies ULC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 22 patents, ranking #818 of 7,127 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Novadaq Technologies ULC's patent grant rate increasing or decreasing?

Novadaq Technologies ULC's recent grant velocity is -62% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Novadaq Technologies ULC's patents?

Novadaq Technologies ULC's patents average 23.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Novadaq Technologies ULC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Novadaq Technologies ULC

USPTO PatentsView assignee record - 29 granted patents across 12 technology areas, recorded in grant years 2018–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Novadaq ranks #10,710 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 12 technology areas.

#10,710
of 49,997 US assignees by volume: Top 42%
by Innovation Score (37.9/100): 23.2
avg claims per patent: -62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10710 · Foreign Corporation #10,710 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,710/49,997
PHOTO-FINISH NextInput
CPC-FOCUS A61B · 12 areas
INNOV-THIN 37.9/100
CLAIMS-DENSE 23.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -62% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: NextInput, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Novadaq’s 37.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (31%) Velocity 0.0 pts (0%) Breadth 12.2 pts (32%) Claim depth 13.9 pts (37%)

Qualcomm Incorporated · highest

85
CUE Health · near

38
JAC Products · near

38
Mavenir Systems · near

38
Novadaq ULC · this assignee

38
Osiris Therapeutics · near

38
3D Lighting… · lowest

7

What this shows Novadaq's Innovation Score is 37.9/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Novadaq?

Each dot is one of Novadaq’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novadaq’s own 23.2 claims/patent is ABOVE the 8.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Novadaq vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Novadaq's grants concentrate

Novadaq Technologies ULC is a focused PatentsView assignee: 12 CPC subclasses with 75.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (15 grants) versus a trough of 1 in 2021. By volume, Novadaq sits between NextInput, Inc. and Osmose Utilities Services, Inc..

Nextinput

29
Nihon Parkerizing

29
Ningbo Fotile Kit…

29
Northern Tool & E…

29
Nubis Communicati…

29
ODK Technology PTE

29
Olatec Therapeuti…

29
Osmose Utilities…

29
Novadaq ULC ◀

29

What this shows Novadaq holds 29 patents at rank #10,710, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Novadaq

By rank, the assignees closest to #10,710 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Novadaq's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Novadaq, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Novadaq ranks #818 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

CUE Health Inc. 38 Osiris Therapeutics, Inc. 38 JAC Products, Inc. 38 Mavenir Systems, Inc. 38

Novadaq's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Novadaq Technologies ULC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	6	20.7%
2019	15	51.7%
2020	7	24.1%
2021	1	3.4%

Which technologies does Novadaq Technologies ULC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 22

G06T - Image Data Processing OR Generation, IN General 9

H04N - Pictorial Communication, e.g. Television 6

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

G02B - Optical Elements, Systems OR Apparatus 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

G03B - Apparatus OR Arrangements FOR Taking Photographs OR FOR Projecting OR Viewing THEM; Apparatus OR Arrangements Employing Analogous Techniques Using Waves Other Than Optical WAVES; Accessories Therefor 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Novadaq Technologies ULC's patent record in context - here's where to go next.

Novadaq Technologies ULC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 75.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #10,710 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Novadaq Technologies ULC against NextInput, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.